Caffeine Completed Phase 4 Trials for Caffeine (DB00201)

Also known as: Caffeine measurement / Blood caffeine

IndicationStatusPhase
DBCOND0032271 (Caffeine)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01783561Early Versus Routine Caffeine Administration in Extremely Preterm NeonatesPrevention